EUVIMEDOpdag EUVIMED
Crossref

Rebalancing viral and immune damage versus repair prevents death from lethal influenza infection

Hiroshi Ichise iD, Emily Speranza iD, Federica La Russa iD, Tibor Z Veres iD, Colin J Chu iD, Anita Gola, Beatrice H Clark iD, Ronald N Germain iD

Science · 2025-11-20 · 390 (6775)

DOI: 10.1126/science.adr4635 ↗

At a glance

Journal article in Science, published on 2025-11-20. Written by Hiroshi Ichise and 7 co-authors. Institution: Lymphocyte Biology Section, Laboratory of Immune System Biology, National Institute of Allergy and Infectious Diseases, National Institutes of Health…. Major MEDLINE topics: Lung, Neutrophils, Orthomyxoviridae Infections, Pneumonia, Viral. Cited 14 times so far (Crossref); 64 references.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Maintaining tissue function while eliminating infected cells is fundamental, and inflammatory damage plays a major contribution to lethality after lung infection. We tested 50 immunomodulatory regimes to determine their ability to protect mice from lethal infection. Only neutrophil depletion soon after infection prevented death from influenza. This result suggests that the infected host passed an early tipping point after which limiting innate damage alone could not rescue lung function. We investigated treatments that could have efficacy when administered later in infection. We found that partial limitation of viral spread together with enhancement of epithelial repair, by interferon blockade or limiting CD8 + T cell–mediated killing of epithelial cells, reduced lethality. This finding highlights the importance of rebalancing repair and damage processes in the survival of pulmonary infections.

Subjects

MeSH terms (MEDLINE)

LungNeutrophilsOrthomyxoviridae InfectionsPneumonia, ViralAdaptive ImmunityImmunomodulationAnimalsFemaleMiceCD8-Positive T-LymphocytesEpithelial CellsImmunity, InnateInterferonsLymphocyte DepletionMice, Inbred C57BLOseltamivirAntiviral AgentsEnzyme InhibitorsImmunomodulating Agents

Substances

InterferonsOseltamivirAntiviral AgentsEnzyme InhibitorsImmunomodulating Agents

Authors and institutions

  • Lymphocyte Biology Section, Laboratory of Immune System Biology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
  • Florida Research and Innovation Center, Cleveland Clinic Lerner Research Institute, Port Saint Lucie, FL, USA.
  • UCL Institute of Ophthalmology, University College London, London, UK.
  • Center for Advanced Tissue Imaging, Laboratory of Immune System Biology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.

ORCID profiles: Hiroshi Ichise, Emily Speranza, Federica La Russa, Tibor Z Veres, Colin J Chu, Beatrice H Clark, Ronald N Germain

Cite

APA

Ichise, H., Speranza, E., La Russa, F., Veres, T. Z., Chu, C. J., Gola, A., Clark, B. H., & Germain, R. N. (2025). Rebalancing viral and immune damage versus repair prevents death from lethal influenza infection. Science, 390(6775). https://doi.org/10.1126/science.adr4635

Vancouver

Ichise H, Speranza E, La Russa F, Veres TZ, Chu CJ, Gola A, et al. Rebalancing viral and immune damage versus repair prevents death from lethal influenza infection. Science. 2025;390(6775). doi:10.1126/science.adr4635

BibTeX
@article{Ichise2025,
  author = {Ichise, Hiroshi and Speranza, Emily and La Russa, Federica and Veres, Tibor Z and Chu, Colin J and Gola, Anita and Clark, Beatrice H and Germain, Ronald N},
  title = {Rebalancing viral and immune damage versus repair prevents death from lethal influenza infection},
  journal = {Science},
  year = {2025},
  volume = {390},
  number = {6775},
  doi = {10.1126/science.adr4635}
}
Start for free →